Fei Geng Selected Research

Lung Neoplasms (Lung Cancer)

1/2021	Fast DNA Vaccination Strategy Elicits a Stronger Immune Response Dependent on CD8+CD11c+ Cell Accumulation.
1/2018	Soluble PD-1-based vaccine targeting MUC1 VNTR and survivin improves anti-tumor effect.
12/2008	E-cadherin core fucosylation regulates nuclear beta-catenin accumulation in lung cancer cells.
10/2004	The expression of core fucosylated E-cadherin in cancer cells and lung cancer patients: prognostic implications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fei Geng Research Topics

Disease

16	Neoplasms (Cancer) 11/2020 - 10/2004
7	Breast Neoplasms (Breast Cancer) 01/2020 - 06/2012
4	Lung Neoplasms (Lung Cancer) 01/2021 - 10/2004
4	Glioma (Gliomas) 01/2019 - 01/2016
3	Neoplasm Metastasis (Metastasis) 12/2019 - 10/2004
2	Vaccinia 11/2020 - 12/2016
1	Silicosis 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020
1	Adenocarcinoma of Lung 01/2020
1	Cognitive Dysfunction 08/2018
1	Adenocarcinoma 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 01/2018
1	Anxiety Disorders (Anxiety Disorder) 01/2018
1	Glioblastoma (Glioblastoma Multiforme) 01/2018
1	Melanoma (Melanoma, Malignant) 01/2016
1	Carcinoma (Carcinomatosis) 01/2016
1	Mercury Poisoning (Poisoning, Mercury) 08/2010
1	Laryngeal Neoplasms (Laryngeal Cancer) 07/2005
1	Hepatocellular Carcinoma (Hepatoma) 07/2005
1	Lymphatic Metastasis 07/2005

Drug/Important Bio-Agent (IBA)

10	VaccinesIBA 01/2021 - 01/2016
6	A-Form DNA (A-DNA)IBA 01/2021 - 01/2016
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2012
5	AntigensIBA 11/2020 - 01/2016
5	DNA VaccinesIBA 11/2020 - 01/2016
4	SurvivinIBA 11/2020 - 01/2016
4	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2016
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2017 - 01/2016
3	Cadherins (E-Cadherin)IBA 06/2012 - 10/2004
2	Cancer VaccinesIBA 11/2020 - 12/2016
2	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 01/2016
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 01/2018
2	Interleukin-10 (Interleukin 10)IBA 02/2017 - 01/2016
2	CytokinesIBA 02/2017 - 01/2016
1	goralatideIBA 01/2021
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2021
1	ElastinIBA 01/2021
1	MVA vaccineIBA 11/2020
1	Serine Proteases (Serine Protease)IBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 01/2020
1	Estrogen ReceptorsIBA 12/2019
1	Insulin-Like PeptidesIBA 08/2018
1	tongluoIBA 08/2018
1	Therapeutic UsesIBA 08/2018
1	Gadolinium DTPA (Magnevist)FDA Link 01/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018
1	serotonin 6 receptorIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	AcidsIBA 01/2018
1	Alkylating AgentsIBA 02/2017
1	CollagenIBA 05/2016
1	Combined VaccinesIBA 01/2016
1	Interleukin-2 (IL2)IBA 01/2016
1	salvinIBA 08/2010
1	beta CateninIBA 12/2008
1	IntegrinsIBA 07/2005
1	GlycoconjugatesIBA 07/2005
1	SulfotransferasesIBA 07/2005
1	SelectinsIBA 07/2005
1	Indicators and Reagents (Reagents)IBA 10/2004

Therapy/Procedure

5	Therapeutics 11/2020 - 09/2010
4	Immunotherapy 01/2020 - 05/2016
3	Drug Therapy (Chemotherapy) 02/2017 - 09/2010
1	Moxibustion 08/2018
1	Aftercare (After-Treatment) 06/2012